Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo, J Tu - Pathology & Oncology …, 2020 - Springer
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage

P Luo, S Wu, Y Yu, X Ming, S Li… - Pathology oncology …, 2020 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

[PDF][PDF] Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo… - Pathology & Oncology …, 2020 - por-journal.com
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage.

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo, J Tu - 2019 - cabidigitallibrary.org
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo… - … Oncology Research: POR, 2019 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage

P Luo, S Wu, Y Yu, X Ming, S Li… - Pathology Oncology …, 2019 - search.proquest.com
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

[引用][C] Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo… - Pathology & Oncology …, 2019 - cir.nii.ac.jp
Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and
Diagnosing Hepatocellular Carcinoma at an Earlier Stage | CiNii Research CiNii 国立情報学 …

Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.

P Luo, S Wu, Y Yu, X Ming, S Li… - Pathology & Oncology …, 2020 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

[PDF][PDF] Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage

P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo… - Pathology & Oncology …, 2020 - por-journal.com
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …